DNM3A Polyclonal Antibody

CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated.

The DNM3A Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of Dynamin 3A (DNM3A) protein expression in various biological samples. This antibody is produced using advanced immunization techniques, ensuring high affinity and sensitivity towards DNM3A.

DNM3A is a member of the dynamin family of GTPases, which play a crucial role in endocytosis and vesicle trafficking processes. It is primarily expressed in the brain and spinal cord, where it is involved in synaptic vesicle recycling and neurotransmitter release. Dysregulation of DNM3A has been implicated in various neurological disorders, making it an important target for research and diagnostic purposes.

The DNM3A Polyclonal Antibody has been rigorously validated for its specificity and performance in various applications, including Western blotting, immunohistochemistry, and immunofluorescence. It exhibits minimal cross-reactivity with other dynamin family members, ensuring accurate and reliable results.

This antibody is supplied as a liquid formulation, ready for immediate use. It is provided in a convenient size and concentration, allowing for easy customization and optimization of experimental conditions. The DNM3A Polyclonal Antibody is manufactured under strict quality control standards, ensuring consistent and reproducible results.

In summary, the DNM3A Polyclonal Antibody is a highly specific and reliable tool for the detection and analysis of DNM3A protein expression. Its exceptional performance and versatility make it an ideal choice for researchers and clinicians studying the role of DNM3A in various neurological disorders and cellular processes.